Showing results (841-850 of 1,393) with videos related to

Sort By:
Pageof 140
Frontiers in Molecular Neuroscience|March 4, 2026
T2-FLAIR hyperintensities in the inferior cerebellar peduncles and their association with clinical symptoms, molecular and MRI markers in male FMR1 premutation carriersAndrea Elias-Mas, Irene Paracuellos-Ayala, Jun Yi Wang, et al.
Current Drug Targets|June 10, 2016
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer TreatmentGabriella Misso, Mayra Rachele Zarone, Anna Grimaldi, et al.
Oncology Reports|March 27, 2012
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trialsDomenico Ciliberto, Ubaldo Prati, Laura Roveda, et al.
Oncotarget|December 17, 2017
Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatmentLavinia Raimondi, Angela De Luca, Viviana Costa, et al.
Clinical Interventions in Aging|March 13, 2020
Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's DiseaseElber Yuksel Aydin, Andrea Schneider, Dragana Protic, et al.
Critical Reviews in Oncology/Hematology|October 9, 2018
The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysisNicoletta Staropoli, Domenico Ciliberto, Teresa Del Giudice, et al.
Panminerva Medica|August 5, 1998
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiencyM Maccario, S Grottoli, G Aimaretti, et al.
Frontiers in Psychiatry|August 30, 2024
Transcranial alternating current stimulation for neuropsychiatric disorders: a systematic review of treatment parameters and outcomesFatemeh Gholamali Nezhad, Josh Martin, Vanessa K Tassone, et al.
International Journal of Molecular Sciences|September 9, 2023
Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTASMarwa Zafarullah, Jie Li, Michelle R Salemi, et al.
Heliyon|August 10, 2023
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysisDomenico Ciliberto, Giulio Caridà, Nicoletta Staropoli, et al.
Pageof 140